Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Two cases of cystic artery pseudoaneurysm rupture due to acute cholecystitis with gallstone impaction in the neck.

Kaida S, Arahata K, Itou A, Takarabe S, Kimura K, Kishikawa H, Nishida J, Fujiyama Y, Takigawa Y, Matsui J.

Nihon Shokakibyo Gakkai Zasshi. 2016 Sep;113(9):1572-81. doi: 10.11405/nisshoshi.113.1572.

PMID:
27593367
2.

Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen.

Kishikawa H, Kimura K, Ito A, Arahata K, Takarabe S, Kaida S, Miyauchi J, Miura S, Nishida J.

Anticancer Res. 2015 Dec;35(12):6765-71. Erratum in: Anticancer Res. 2016 Jan;36(1):477.

PMID:
26637894
3.

Helicobacter pylori Antibody Titer and Gastric Cancer Screening.

Kishikawa H, Kimura K, Takarabe S, Kaida S, Nishida J.

Dis Markers. 2015;2015:156719. doi: 10.1155/2015/156719. Review.

4.

Fundic gland polyps accurately predict a low risk of future gastric carcinogenesis.

Kishikawa H, Kaida S, Takarabe S, Miyoshi J, Matsukubo T, Miyauchi J, Tanaka Y, Miura S, Nishida J.

Clin Res Hepatol Gastroenterol. 2014 Sep;38(4):505-12. doi: 10.1016/j.clinre.2014.01.008.

5.

Persistent hiccups followed by cardiorespiratory arrest.

Okada S, Takarabe S, Nogawa S, Abe T, Morishita T, Mori M, Nishida J.

Lancet. 2012 Oct 20;380(9851):1444. doi: 10.1016/S0140-6736(12)60900-3. No abstract available.

PMID:
23084457
6.

Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status.

Kishikawa H, Nishida J, Ichikawa H, Kaida S, Takarabe S, Matsukubo T, Miura S, Morishita T, Hibi T.

Helicobacter. 2011 Dec;16(6):427-33. doi: 10.1111/j.1523-5378.2011.00868.x.

PMID:
22059393
7.

Serum nitrate/nitrite concentration correlates with gastric juice nitrate/nitrite: a possible marker for mutagenesis of the proximal stomach.

Kishikawa H, Nishida J, Ichikawa H, Kaida S, Matsukubo T, Miura S, Morishita T, Hibi T.

Digestion. 2011;84(1):62-9. doi: 10.1159/000322221.

PMID:
21494035
8.

Prediction of fasting gastric pH using serum biological markers.

Kishikawa H, Nishida J, Ichikawa H, Kaida S, Matsukubo T, Miura S, Morishita T, Hibi T.

Hepatogastroenterology. 2010 Nov-Dec;57(104):1602-7.

PMID:
21443128
9.

[A case of adult intussusceptions with multiple colon cancer].

Kaida S, Nishida J, Kishikawa H, Ichikawa H, Morishita T, Takayama S, Sato M.

Nihon Shokakibyo Gakkai Zasshi. 2010 Jan;107(1):77-83. Review. Japanese.

PMID:
20057186
10.

Lipopolysaccharides stimulate adrenomedullin synthesis in intestinal epithelial cells: release kinetics and secretion polarity.

Kishikawa H, Nishida J, Ichikawa H, Kaida S, Morishita T, Miura S, Hibi T.

Peptides. 2009 May;30(5):906-12. doi: 10.1016/j.peptides.2009.01.023.

PMID:
19428768
11.

Treatment of hepatitis C virus with peg-interferon and ribavirin combination therapy significantly affects lipid metabolism.

Tada S, Saito H, Ebinuma H, Ojiro K, Yamagishi Y, Kumagai N, Inagaki Y, Masuda T, Nishida J, Takahashi M, Nagata H, Hibi T.

Hepatol Res. 2009 Feb;39(2):195-9. doi: 10.1111/j.1872-034X.2008.00439.x.

PMID:
19054155
12.

Role of erythrocytes as a reservoir for ribavirin and relationship with adverse reactions in the early phase of interferon combination therapy for chronic hepatitis C virus infections.

Saito H, Tada S, Ebinuma H, Ishii H, Kashiwazaki K, Takahashi M, Tsukada N, Nishida J, Tanaka S, Shiozaki H, Hibi T.

J Clin Microbiol. 2006 Oct;44(10):3562-8.

13.

Induction therapy with twice-daily interferon-beta does not improve the therapeutic efficacy of consensus interferon monotherapy for chronic hepatitis C.

Saito H, Tada S, Ebinuma H, Ishii H, Kashiwazaki K, Nishida J, Yoshida T, Zeki S, Yoshida H, Yoshioka M, Inagaki Y, Kumagai N, Hibi T.

Keio J Med. 2006 Sep;55(3):111-7.

14.

Ethanol-induced CXC-chemokine synthesis and barrier dysfunction in intestinal epithelial cells.

Kishikawa H, Miura S, Nishida J, Nakano M, Hirano E, Sudo N, Morishita T, Ishii H.

Alcohol Clin Exp Res. 2005 Dec;29(12):2116-22.

PMID:
16385181
15.

[A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy].

Ogata T, Nishida J, Seo K, Hamaya M, Kouno T, Sato S, Yoshida K, Tsuchida A, Aoki T.

Gan To Kagaku Ryoho. 2005 Dec;32(13):2113-6. Japanese.

PMID:
16352939
16.

Tongue metastasis as an initial presentation of a lung cancer.

Terashima T, Matsuzaki T, Kawada I, Nishida J, Tanaka Y, Morishita T, Takeyasu Y, Yamane GY, Uchiyama T.

Intern Med. 2004 Aug;43(8):727-30.

17.

Chronic ischemic proctitis: case report and review.

Kishikawa H, Nishida J, Hirano E, Nakano M, Arakawa K, Morishita T, Kawashima J, Koide O, Tanaka Y, Ishii H.

Gastrointest Endosc. 2004 Aug;60(2):304-8. Review. No abstract available.

PMID:
15278070
18.

Additive therapeutic effects of the liver extract preparation mixture adelavin-9 on interferon-beta treatment for chronic hepatitis C.

Ebinuma H, Saito H, Tada S, Masuda T, Kamiya T, Nishida J, Yoshioka M, Ishii H; KEIO Interferon-beta Study Group..

Hepatogastroenterology. 2004 Jul-Aug;51(58):1109-14.

PMID:
15239256
19.

Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met.

Tomita K, Azuma T, Kitamura N, Nishida J, Tamiya G, Oka A, Inokuchi S, Nishimura T, Suematsu M, Ishii H.

Gastroenterology. 2004 Mar;126(3):873-85.

PMID:
14988841
20.

Hepatic microvascular development in relation to the morphogenesis of hepatocellular plates in neonatal rats.

McCuskey RS, Ekataksin W, LeBouton AV, Nishida J, McCuskey MK, McDonnell D, Williams C, Bethea NW, Dvorak B, Koldovsky O.

Anat Rec A Discov Mol Cell Evol Biol. 2003 Nov;275(1):1019-30.

Items per page

Supplemental Content

Loading ...
Support Center